KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exact Sciences (EXAS) Debt to Equity (2016 - 2024)

Exact Sciences has reported Debt to Equity over the past 15 years, most recently at $0.02 for Q1 2024.

  • Quarterly Debt to Equity fell 2.39% to $0.02 in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $0.02 through Mar 2024, down 2.39% year-over-year, with the annual reading at $0.02 for FY2023, 3.25% down from the prior year.
  • Debt to Equity was $0.02 for Q1 2024 at Exact Sciences, roughly flat from $0.02 in the prior quarter.
  • Over five years, Debt to Equity peaked at $0.02 in Q4 2022 and troughed at $0.01 in Q1 2021.
  • The 5-year median for Debt to Equity is $0.02 (2023), against an average of $0.01.
  • Year-over-year, Debt to Equity plummeted 97.23% in 2020 and then soared 159.41% in 2022.
  • A 5-year view of Debt to Equity shows it stood at $0.01 in 2020, then crashed by 37.96% to $0.01 in 2021, then soared by 164.99% to $0.02 in 2022, then dropped by 3.25% to $0.02 in 2023, then increased by 0.4% to $0.02 in 2024.
  • Per Business Quant, the three most recent readings for EXAS's Debt to Equity are $0.02 (Q1 2024), $0.02 (Q4 2023), and $0.02 (Q3 2023).